ADAM19 antibody (PE-Cy7)
Quick Overview for ADAM19 antibody (PE-Cy7) (ABIN758814)
Target
See all ADAM19 (Adam19) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Cross-Reactivity
- Human
-
Predicted Reactivity
- Mouse,Rat,Pig
-
Purification
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human ADAM19
-
Isotype
- IgG
-
-
-
-
Application Notes
-
FCM(1:100-500)
Optimal working dilution should be determined by the investigator. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Expiry Date
- 12 months
-
-
- ADAM19 (Adam19) (ADAM Metallopeptidase Domain 19 (Adam19))
-
Alternative Name
- ADAM19
-
Background
-
Synonyms: MLTNB, FKSG34, MADDAM, Disintegrin and metalloproteinase domain-containing protein 19, ADAM 19, Meltrin-beta, Metalloprotease and disintegrin dendritic antigen marker, ADAM19
Background: Participates in the proteolytic processing of beta-type neuregulin isoforms which are involved in neurogenesis and synaptogenesis, suggesting a regulatory role in glial cell. Also cleaves alpha-2 macroglobulin. May be involved in osteoblast differentiation and/or osteoblast activity in bone (By similarity).
-
Molecular Weight
- 82kDa
-
Gene ID
- 8728
-
UniProt
- Q9H013
Target
-